Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FENRETINIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 114 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wu, JM; DiPietrantonio, AM; Hsieh, TC
      Mechanism of fenretinide (4-HPR)-induced cell death

      APOPTOSIS
    2. Follen, M; Atkinson, EN; Schottenfeld, D; Malpica, A; West, L; Lippman, S; Zou, CP; Hittelman, WN; Lotan, R; Hong, WK
      A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix

      CLINICAL CANCER RESEARCH
    3. Tamagawa, K; Shimizu, K; Ebine, T; Maitani, Y; Fukui, T; Kawai, K; Takahashi, N
      Antitumor efficacy in vitro and in vivo of falconensones, a new type of polyene

      CLINICAL CANCER RESEARCH
    4. Smith, MA; Anderson, B
      Where to next with retinoids for cancer therapy?

      CLINICAL CANCER RESEARCH
    5. Sun, SY; Yue, P; Kelloff, GJ; Steele, VE; Lippman, SM; Hong, WK; Lotan, R
      Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    6. Weiss, KL; Alshafie, G; Chapman, JS; Mershon, SM; Abou-Issa, H; Clagett-Dame, M; Curley, RW
      An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide: Synthesis andpreliminary biological studies

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    7. Pettersson, F; Colston, KW; Dalgleish, AG
      Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells

      PANCREAS
    8. Ulukaya, E; Kurt, A; Wood, EJ
      4-(N-hydroxyphenyl)retinamide can selectively induce apoptosis in human epidermoid carcinoma cells but not in normal dermal fibroblasts

      CANCER INVESTIGATION
    9. Um, SJ; Lee, SY; Kim, EJ; Han, HS; Koh, YM; Hong, KJ; Sin, HS; Park, JS
      Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells

      CANCER LETTERS
    10. Merritt, G; Aliprandis, ET; Prada, F; Rigas, B; Kashfi, K
      The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines

      CANCER LETTERS
    11. Dietze, EC; Yee, L; Seewaldt, VL
      Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide

      BREAST CANCER RESEARCH AND TREATMENT
    12. Antonyak, MA; Singh, US; Lee, DA; Boehm, JE; Combs, C; Zgola, MM; Page, RL; Cerione, RA
      Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    13. Ribatti, D; Alessandri, G; Baronio, M; Raffaghello, L; Cosimo, E; Marimpietri, D; Montaldo, PG; De Falco, G; Caruso, A; Vacca, A; Ponzoni, M
      Inhibition of neuroblastoma-induced angiogenesis by fenretinide

      INTERNATIONAL JOURNAL OF CANCER
    14. Torrisi, R; Decensi, A; Formelli, F; Camerini, T; De Palo, G
      Chemoprevention of breast cancer with fenretinide

      DRUGS
    15. Appierto, V; Cavadini, E; Pergolizzi, R; Cleris, L; Lotan, R; Canevari, S; Formelli, F
      Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

      BRITISH JOURNAL OF CANCER
    16. Veronesi, U; Decensi, A
      Retinoids for ovarian cancer prevention: Laboratory data set the stage forthoughtful clinical trials

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    17. Dawson, MI
      The importance of vitamin A in nutrition

      CURRENT PHARMACEUTICAL DESIGN
    18. Kurie, JM; Lee, JS; Khuri, FR; Mao, L; Morice, RC; Lee, JJ; Walsh, GL; Broxson, A; Lippman, SM; Ro, JY; Kemp, BL; Liu, D; Fritsche, HA; Xu, XC; Lotan, R; Hong, WK
      N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium

      CLINICAL CANCER RESEARCH
    19. Decensi, A; Torrisi, R; Bruno, S; Costantini, M; Curotto, A; Nicolo, G; Malcangi, B; Baglietto, L; Bruttini, GP; Gatteschi, B; Rondanina, G; Varaldo, M; Perloff, M; Malone, WF; Bruzzi, P
      Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    20. Decensi, A; Costa, A
      Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    21. Formelli, F; Cleris, L
      Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line

      EUROPEAN JOURNAL OF CANCER
    22. Takahashi, N; Kubo, Y; Iwahori, A; Kawai, K; Fukui, T
      Induction of apoptosis in the human promyelocytic leukemia cell line HL60 by falconensone A and its derivatives, new polyenes

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    23. Takahashi, N
      Antioxidant properties of N-(4-hydroxyphenyl)retinamide (fenretinide)

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    24. Zwiebel, JA
      New agents for acute myelogenous leukemia

      LEUKEMIA
    25. Conley, B; O'Shaughnessy, J; Prindiville, S; Lawrence, J; Chow, C; Jones, E; Merino, MJ; Kaiser-Kupfer, MI; Caruso, RC; Podger, M; Goldspiel, B; Venzon, D; Danforth, D; Wu, SL; Noone, M; Goldstein, J; Cowan, KH; Zujewski, J
      Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high riskfor developing invasive breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    26. Lotan, Y; Xu, XC; Shalev, M; Lotan, R; Williams, R; Wheeler, TM; Thompson, TC; Kadmon, D
      Differential expression of nuclear retinoid receptors in normal and malignant prostates

      JOURNAL OF CLINICAL ONCOLOGY
    27. Formelli, F
      Quality control for HPLC assay and surrogate end point biomarkers from thefenretinide (4-HPR) breast cancer prevention trial

      JOURNAL OF CELLULAR BIOCHEMISTRY
    28. Decensi, A; Bonanni, B; Guerrieri-Gonzaga, A; Torrisi, R; Manetti, L; Robertson, C; De Palo, G; Formelli, F; Costa, A; Veronesi, U
      Chemoprevention of breast cancer: The Italian experience

      JOURNAL OF CELLULAR BIOCHEMISTRY
    29. Baglietto, L; Torrisi, R; Arena, G; Tosetti, F; Gonzaga, AG; Pasquetti, W; Robertson, C; Decensi, A
      Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer

      CANCER DETECTION AND PREVENTION
    30. Vaccari, M; Silingardi, P; Argnani, A; Horn, W; Giungi, M; Mascolo, MG; Grilli, S; Colacci, A
      In vitro effects of fenretinide on cell-matrix interactions

      ANTICANCER RESEARCH
    31. Reynolds, CP; Wang, Y; Melton, LJ; Einhorn, PA; Slamon, DJ; Maurer, BJ
      Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide

      MEDICAL AND PEDIATRIC ONCOLOGY
    32. Lovat, PE; Ranalli, M; Bernassola, F; Tilby, M; Malcolm, AJ; Pearson, ADJ; Piacentini, M; Melino, G; Redfern, CPF
      Distinct properties of fenretinide and CD437 lead to synergistic responseswith chemotherapeutic reagents

      MEDICAL AND PEDIATRIC ONCOLOGY
    33. Lovat, PE; Ranalli, M; Annichiarrico-Petruzzelli, M; Bernassola, F; Piacentini, M; Malcolm, AJ; Pearson, ADJ; Melino, G; Redfern, CPF
      Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma

      EXPERIMENTAL CELL RESEARCH
    34. Yang, XL; Hao, YW; Ding, ZH; Pater, A
      BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in humancervical carcinoma cells

      EXPERIMENTAL CELL RESEARCH
    35. Matthay, KK; Reynolds, CP
      Is there a role for retinoids to treat minimal residual disease in neuroblastoma?

      BRITISH JOURNAL OF CANCER
    36. Ciolino, HP; Wang, TTY; Sathyamoorthy, N
      Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide

      BRITISH JOURNAL OF CANCER
    37. Saitoh, Y; Goto, T; Puduvalli, VK; Murakami, M; Kochi, M; Levin, VA; Kyritsis, AP; Ushio, Y
      Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    38. Shen, JC; Wang, TTY; Chang, S; Hursting, SD
      Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis

      MOLECULAR CARCINOGENESIS
    39. Kalemkerian, GP; Ou, XL
      Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    40. Urban, D; Myers, R; Manne, U; Weiss, H; Mohler, J; Perkins, D; Markiewicz, M; Lieberman, R; Kelloff, G; Marshall, M; Grizzle, W
      Evaluation of biomarker modulation by fenretinide in prostate cancer patients

      EUROPEAN UROLOGY
    41. Bosland, MC
      Use of animal models in defining efficacy of chemoprevention agents against prostate cancer

      EUROPEAN UROLOGY
    42. McCormick, DL; Rao, KVN
      Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat

      EUROPEAN UROLOGY
    43. Webber, MM; Bello-DeOcampo, D; Quader, S; Deocampo, ND; Metcalfe, WS; Sharp, RM
      Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)

      CLINICAL & EXPERIMENTAL METASTASIS
    44. Zujewski, J; Pai, L; Wakefield, L; Giusti, R; Dorr, FA; Flanders, C; Caruso, R; Kaiser, M; Goodman, L; Merino, M; Gossard, M; Noone, MA; Denicoff, A; Venzon, D; Cowan, KH; O'Shaughnessy, JA
      Tamoxifen and fenretinide in women with metastatic breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    45. Herbert, BS; Sanders, BG; Kline, K
      N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells

      NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
    46. Jinno, H; Steiner, MG; Mehta, RG; Osborne, MP; Telang, NT
      Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide

      CARCINOGENESIS
    47. Sun, SY; Yue, P; Lotan, R
      Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells

      MOLECULAR PHARMACOLOGY
    48. Altieri, P; Caridi, G; Chiesa, V; Ponzoni, M; Ghiggeri, GM
      N-(4-hydroxphenyl) retinamide inhibits cystogenesis by polycystic epithelial cell lines in vitro

      LIFE SCIENCES
    49. Montaldo, PG; Pagnan, G; Pastorino, F; Chiesa, V; Raffaghello, L; Kirchmeier, M; Allen, TM; Ponzoni, M
      N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death

      INTERNATIONAL JOURNAL OF CANCER
    50. Lewis, KC; Hochadel, JF
      Retinoid metabolism in the prostate: Effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide

      CANCER RESEARCH
    51. Sun, SY; Li, WB; Yue, P; Lippman, SM; Hong, WK; Lotan, R
      Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms

      CANCER RESEARCH
    52. Clifford, JL; Menter, DG; Wang, M; Lotan, R; Lippman, SM
      Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells

      CANCER RESEARCH
    53. Chiantore, MV; Giandomenico, V; De Luca, LM
      Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: Correlation with tissue transglutaminase

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    54. Veronesi, U; De Palo, G; Marubini, E; Costa, A; Formelli, F; Mariani, L; Decensi, A; Camerini, T; Del Turco, MR; Di Mauro, MG; Muraca, MG; Del Vecchio, M; Pinto, C; D'Aiuto, G; Boni, C; Campa, T; Magni, A; Miceli, R; Perloff, M; Malone, WF; Sporn, MB
      Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    55. Maurer, BJ; Metelitsa, LS; Seeger, RC; Cabot, MC; Reynolds, CP
      Increase of ceramide and induction of mixed apoptosis necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    56. MEHTA RR; HAWTHORNE ME; GRAVES JM; MEHTA RG
      METABOLISM OF N-[4-HYDROXYPHENYL]RETINAMIDE (4-HPR) TO N-[4-METHOXYPHENYL]RETINAMIDE (4-MPR) MAY SERVE AS A BIOMARKER FOR ITS EFFICACY AGAINST HUMAN BREAST-CANCER AND MELANOMA-CELLS

      European journal of cancer
    57. PAGNAN G; CARIDI G; MONTALDO PG; BADO M; CHIESA V; ALLEN TM; PONZONI M
      APOPTOSIS OF HUMAN NEUROBLASTOMA-CELLS INDUCED BY LIPOSOME-CAPSULATEDFENRETINIDE

      Journal of liposome research
    58. LIPPMAN SM; BENNER SE; FRITSCHE HA; LEE JS; HONG WK
      THE EFFECT OF 13-CIS-RETINOIC ACID CHEMOPREVENTION ON HUMAN SERUM RETINOL LEVELS

      Cancer detection and prevention
    59. SPRINGER LN; STEWART BW
      N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED DEATH IN HUMAN LYMPHOBLASTOID-CELLS - 50 KB DNA BREAKAGE AS A MEANS OF DISTINGUISHING APOPTOSIS FROM NECROSIS

      Cancer letters
    60. LIEBERMAN R; CROWELL JA; HAWK ET; BOONE CW; SIGMAN CC; KELLOFF GJ
      DEVELOPMENT OF NEW CANCER CHEMOPREVENTION AGENTS - ROLE IN PHARMACOKINETIC PHARMACODYNAMIC AND INTERMEDIATE END-POINT BIOMARKER MONITORING/

      Clinical chemistry
    61. GRUNT TW; DITTRICH E; OFFTERDINGER M; SCHNEIDER SM; DITTRICH C; HUBER H
      EFFECTS OF RETINOIC ACID AND FENRETINIDE ON THE C-ERBB-2 EXPRESSION, GROWTH AND CISPLATIN SENSITIVITY OF BREAST-CANCER CELLS

      British Journal of Cancer
    62. CARUSO RC; ZUJEWSKI J; IWATA F; PODGOR MJ; CONLEY BA; AYRES LM; KAISERKUPFER MI
      EFFECTS OF FENRETINIDE (4-HPR) ON DARK-ADAPTATION

      Archives of ophthalmology
    63. Takahashi, N; Iwahori, A; Kawai, K; Fukui, T
      Induction of differentiation in human promyelocytic leukemia cell line HL60 by a new type of polyenes, falconensone A and its derivatives

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    64. SABICHI AL; HENDRICKS DT; BOBER MA; BIRRER MJ
      RETINOIC ACID RECEPTOR-BETA EXPRESSION AND GROWTH-INHIBITION OF GYNECOLOGIC CANCER-CELLS BY THE SYNTHETIC RETINOID N-(4-HYDROXYPHENYL) RETINAMIDE

      Journal of the National Cancer Institute
    65. CHAN LNL; ZHANG SL; SHAO JY; WAIKEL R; THOMPSON EA; CHAN TS
      N-(4-HYDROXYPHENYL)RETINAMIDE INDUCES APOPTOSIS IN T-LYMPHOMA AND T-LYMPHOBLASTOID LEUKEMIA-CELLS

      Leukemia & lymphoma
    66. CORADINI D; BIFFI A; PELLIZZARO C; PIRRONELLO E; DIFRONZO G
      COMBINED EFFECT OF TAMOXIFEN OR INTERFERON-BETA AND 4-HYDROXYPHENYLRETINAMIDE ON THE GROWTH OF BREAST-CANCER CELL-LINES

      Tumor biology
    67. TRUMP DL; SMITH DC; STIFF D; ADEDOYIN A; DAY R; BAHNSON RR; HOFACKER J; BRANCH RA
      A PHASE-II TRIAL OF ALL-TRANS-RETINOIC ACID IN HORMONE-REFRACTORY PROSTATE-CANCER - A CLINICAL-TRIAL WITH DETAILED PHARMACOKINETIC ANALYSIS

      Cancer chemotherapy and pharmacology
    68. BARUA AB; DUITSMAN PK; KOSTIC D; BARUA M; OLSON JA
      REDUCTION OF SERUM RETINOL LEVELS FOLLOWING A SINGLE ORAL DOSE OF ALL-TRANS-RETINOIC ACID IN HUMANS

      International journal for vitamin and nutrition research
    69. DEPALO G; CAMERINI T; MARUBINI E; COSTA A; FORMELLI F; DELVECCHIO M; MARIANI L; MICELI R; MASCOTTI G; MAGNI A; CAMPA T; DIMAURO MG; ATTILI A; MALTONI C; DELTURCO MR; DECENSI A; DAIUTO G; VERONESI U
      CHEMOPREVENTION TRIAL OF CONTRALATERAL BREAST-CANCER WITH FENRETINIDE- RATIONALE, DESIGN, METHODOLOGY, ORGANIZATION, DATA MANAGEMENT, STATISTICS AND ACCRUAL

      Tumori
    70. CHAN LNL; ZHANG SL; CLOYD M; CHAN TS
      N-(4-HYDROXYPHENYL)RETINAMIDE PREVENTS DEVELOPMENT OF T-LYMPHOMAS IN AKR J MICE/

      Anticancer research
    71. DELIA D; AIELLO A; MERONI L; NICOLINI M; REED JC; PIEROTTI MA
      ROLE OF ANTIOXIDANTS AND INTRACELLULAR FREE-RADICALS IN RETINAMIDE-INDUCED CELL-DEATH

      Carcinogenesis
    72. TAMURA K; NAKAE D; HORIGUCHI K; AKAI H; KOBAYASHI Y; ANDOH N; SATOH H; DENDA A; TSUJIUCHI T; YOSHIJI H; KONISHI Y
      INHIBITION BY N-(4-HYDROXYPHENYL)RETINAMIDE AND ALL-TRANS-RETINOIC ACID OF EXOGENOUS AND ENDOGENOUS DEVELOPMENT OF PUTATIVE PRENEOPLASTIC, GLUTATHIONE-S-TRANSFERASE PLACENTAL FORM-POSITIVE LESIONS IN THE LIVERS OF RATS

      Carcinogenesis
    73. HOLVEN KB; NATARAJAN V; GUNDERSEN TE; MOSKAUG JO; NORUM KR; BLOMHOFF R
      SECRETION OF N-(4-HYDROXYPHENYL) RETINAMIDE-RETINOL-BINDING PROTEIN FROM LIVER PARENCHYMAL-CELLS - EVIDENCE FOR REDUCED AFFINITY OF THE COMPLEX FOR TRANSTHYRETIN

      International journal of cancer
    74. BU SZ; YIN DL; REN XH; JIANG LZ; WU ZJ; GAO QR; PEI G
      PROGESTERONE INDUCES APOPTOSIS AND UP-REGULATION OF P53 EXPRESSION INHUMAN OVARIAN-CARCINOMA CELL-LINES

      Cancer
    75. TAIMI M; BREITMAN TR
      N-4-HYDROXYPHENYLRETINAMIDE ENHANCES RETINOIC ACID-INDUCED DIFFERENTIATION AND RETINOYLATION OF PROTEINS IN THE HUMAN ACUTE PROMYELOCYTIC LEUKEMIA-CELL LINE, NB4, BY A MECHANISM THAT MAY INVOLVE INHIBITION OF RETINOIC ACID CATABOLISM

      Biochemical and biophysical research communications
    76. ORIDATE N; LOTAN D; XU XC; HONG WK; LOTAN R
      DIFFERENTIAL INDUCTION OF APOPTOSIS BY ALL-TRANS-RETINOIC ACID AND N-(4-HYDROXYPHENYL)RETINAMIDE IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA CELL-LINES

      Clinical cancer research
    77. LEWIS KC; ZECH LA; PHANG JM
      EFFECTS OF CHRONIC ADMINISTRATION OF N-(4-HYDROXYPHENYL)RETINAMIDE (4-HPR) IN RATS ON VITAMIN-A METABOLISM IN THE EYE

      European journal of cancer
    78. GREENWALD P
      CANCER RISK-FACTORS FOR SELECTING COHORTS FOR LARGE-SCALE CHEMOPREVENTION TRIALS

      Journal of cellular biochemistry
    79. RITTER SJ; SMITH JE
      MULTIPLE RETINOIDS ALTER LIVER BILE SALT-INDEPENDENT RETINYL ESTER HYDROLASE ACTIVITY, SERUM VITAMIN-A AND SERUM RETINOL-BINDING PROTEIN OFRATS

      Biochimica et biophysica acta (G). General subjects
    80. MOGLIA D; FORMELLI F; BALIVA G; BONO A; ACCETTURI M; NAVA M; DEPALO G
      EFFECTS OF TOPICAL TREATMENT WITH FENRETINIDE (4-HPR) AND PLASMA VITAMIN-A LEVELS IN PATIENTS WITH ACTINIC KERATOSES

      Cancer letters
    81. MARIANI L; FORMELLI F; DEPALO G; MANZARI A; CAMERINI T; CAMPA T; DIMAURO MG; CRIPPA A; DELLEGROTTAGLIE M; DELVECCHIO M; MARUBINI E; COSTA A; VERONESI U
      CHEMOPREVENTION OF BREAST-CANCER WITH FENRETINIDE (4-HPR) - STUDY OF LONG-TERM VISUAL AND OPHTHALMOLOGIC TOLERABILITY

      Tumori
    82. EICHER SA; LOTAN R
      DIFFERENTIAL-EFFECTS OF RETINOIC ACID AND N-(4-HYDROXPHENYL)RETINAMIDE ON HEAD AND NECK SQUAMOUS-CELL CARCINOMA-CELLS

      The Laryngoscope
    83. MATSUURA T; ZHAO Z; ROSS AC
      N-(4-HYDROXYPHENYL)-RETINAMIDE INCREASES LECITHIN - RETINOL ACYLTRANSFERASE ACTIVITY IN RAT-LIVER

      The Journal of nutrition
    84. FANJUL AN; DELIA D; PIEROTTI MA; RIDEOUT D; QIU J; PFAHL M
      4-HYDROXYPHENYL RETINAMIDE IS A HIGHLY SELECTIVE ACTIVATOR OF RETINOID RECEPTORS

      The Journal of biological chemistry
    85. KAZMI SMI; PLANTE RK; VISCONTI V; LAU CY
      COMPARISON OF N-(4-HYDROXYPHENYL)RETINAMIDE AND ALL-TRANS-RETINOIC ACID IN THE REGULATION OF RETINOID RECEPTOR-MEDIATED GENE-EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES

      Cancer research
    86. ZUGMAIER G; JAGER R; GRAGE B; GOTTARDIS MM; HAVEMANN K; KNABBE C
      GROWTH-INHIBITORY EFFECTS OF VITAMIN-D ANALOGS AND RETINOIDS ON HUMANPANCREATIC-CANCER CELLS

      British Journal of Cancer
    87. BRIGATI C; FERRARI N; MEGNA M; RONCELLA S; CUTRONA G; TOSETTI F; VIDALI G
      A RETINOIC ACID-RESISTANT HL-60 CELL CLONE SENSITIVE TO N-(4-HYDROXYPHENYL) RETINAMIDE-MEDIATED CLONAL GROWTH-INHIBITION

      Leukemia & lymphoma
    88. HSIEH TC; NG CY; WU JM
      THE SYNTHETIC RETINOID N-(4-HYDROXYPHENYL) RETINAMIDE (4-HPR) EXERTS ANTIPROLIFERATIVE AND APOPTOSIS-INDUCING EFFECTS IN THE ANDROGEN-INDEPENDENT HUMAN PROSTATIC JCA-1 CELLS

      Biochemistry and molecular biology international
    89. AVIGNOLO C; NIGRO S; GEIDO E; GIARETTI W
      N-(4-HYDROXYPHENYL)RETINAMIDE INDUCES APOPTOSIS IN HUMAN LEUKEMIA HL-60 CELLS AND MEDIATES VIMENTIN DOWN-REGULATION

      International journal of oncology
    90. ORIDATE N; LOTAN D; MITCHELL MF; HONG WK; LOTAN R
      INDUCTION OF APOPTOSIS BY RETINOIDS IN HUMAN CERVICAL-CARCINOMA CELL-LINES

      International journal of oncology
    91. ORIDATE N; LOTAN D; MITCHELL MF; HONG WK; LOTAN R
      INHIBITION OF PROLIFERATION AND INDUCTION OF APOPTOSIS IN CERVICAL-CARCINOMA CELLS BY RETINOIDS - IMPLICATIONS FOR CHEMOPREVENTION

      Journal of cellular biochemistry
    92. DEPALO G; VERONESI U; MARUBINI E; CAMERINI T; CHIESA F; NAVA M; FORMELLI F; DELVECCHIO M; COSTA A; BORACCHI P; MARIANI L
      CONTROLLED CLINICAL-TRIALS WITH FENRETINIDE IN BREAST-CANCER, BASAL-CELL CARCINOMA AND ORAL LEUKOPLAKIA

      Journal of cellular biochemistry
    93. UBELS JL; DENNIS MH; MITCHELL JH; WILEY LA; CURLEY RW
      BIOLOGICAL-ACTIVITY OF N-(4-HYDROXYPHENYL) RETINAMIDE-O-GLUCURONIDE IN CORNEAL AND CONJUNCTIVAL CELLS OF RABBITS AND HUMANS

      Current eye research
    94. SHEIKH MS; SHAO ZM; LI XS; ORDONEZ JV; CONLEY BA; WU SL; DAWSON MI; HAN QX; CHAO WR; QUICK T; NILES RM; FONTANA JA
      N-(4-HYDROXYPHENYL)RETINAMIDE (4-HPR)-MEDIATED BIOLOGICAL ACTIONS INVOLVE RETINOID RECEPTOR-INDEPENDENT PATHWAYS IN HUMAN BREAST-CARCINOMA

      Carcinogenesis
    95. SANI BP; SHEALY YF; HILL DL
      N-(4-HYDROXYPHENYL)RETINAMIDE - INTERACTIONS WITH RETINOID-BINDING PROTEINS RECEPTORS/

      Carcinogenesis
    96. ADAMS WR; SMITH JE; GREEN MH
      EFFECTS OF N-(4-HYDROXYPHENYL)RETINAMIDE ON VITAMIN-A METABOLISM IN RATS

      Proceedings of the Society for Experimental Biology and Medicine
    97. LOTAN R
      RETINOIDS AND APOPTOSIS - IMPLICATIONS FOR CANCER CHEMOPREVENTION ANDTHERAPY

      Journal of the National Cancer Institute
    98. KALEMKERIAN GP; SLUSHER R; RAMALINGAM S; GADGEEL S; MABRY M
      GROWTH-INHIBITION AND INDUCTION OF APOPTOSIS BY FENRETINIDE IN SMALL-CELL LUNG-CANCER CELL-LINES

      Journal of the National Cancer Institute
    99. DECENSI A; FORMELLI F; TORRISI R; DEPALO G; COSTA A
      FENRETINIDE IN BREAST-CANCER CHEMOPREVENTION (REVIEW)

      Oncology Reports
    100. COBLEIGH MA
      BREAST-CANCER AND FENRETINIDE, AN ANALOG OF VITAMIN-A

      Leukemia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:58:01